| Symbol |
Name |
Standardized Value |
|
CRP
|
C-reactive protein, pentraxin-related
|
2.738
|
|
F2
|
coagulation factor II (thrombin)
|
2.665
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
2.615
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
2.61
|
|
ALB
|
albumin
|
2.328
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.308
|
|
IL6
|
interleukin 6
|
2.169
|
|
CD4
|
CD4 molecule
|
2.122
|
|
TNF
|
tumor necrosis factor
|
2.108
|
|
SDC1
|
syndecan 1
|
2.067
|
|
VWF
|
von Willebrand factor
|
2.058
|
|
PLG
|
plasminogen
|
2.056
|
|
IL1B
|
interleukin 1, beta
|
2.019
|
|
F8
|
coagulation factor VIII, procoagulant component
|
1.985
|
|
PRTN3
|
proteinase 3
|
1.983
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
1.952
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
1.916
|
|
ACE
|
angiotensin I converting enzyme
|
1.908
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
1.893
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
1.888
|
|
IL10
|
interleukin 10
|
1.882
|
|
INS
|
insulin
|
1.881
|
|
PLAT
|
plasminogen activator, tissue
|
1.876
|
|
IFNG
|
interferon, gamma
|
1.842
|
|
MPO
|
myeloperoxidase
|
1.834
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.831
|
|
PF4
|
platelet factor 4
|
1.803
|
|
CD8A
|
CD8a molecule
|
1.785
|
|
IL4
|
interleukin 4
|
1.785
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.777
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
1.759
|
|
IL1A
|
interleukin 1, alpha
|
1.753
|
|
ANXA11
|
annexin A11
|
1.729
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.728
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1.728
|
|
THBD
|
thrombomodulin
|
1.728
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.723
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.714
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.714
|
|
CD68
|
CD68 molecule
|
1.705
|
|
IFNA1
|
interferon, alpha 1
|
1.696
|
|
IL5
|
interleukin 5
|
1.68
|
|
IL13
|
interleukin 13
|
1.678
|
|
CD34
|
CD34 molecule
|
1.67
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.667
|
|
ICAM1
|
intercellular adhesion molecule 1
|
1.662
|
|
SELE
|
selectin E
|
1.643
|
|
SLAMF7
|
SLAM family member 7
|
1.64
|
|
CD1E
|
CD1e molecule
|
1.625
|
|
CD1A
|
CD1a molecule
|
1.623
|
|
CD1B
|
CD1b molecule
|
1.607
|
|
F10
|
coagulation factor X
|
1.592
|
|
IL2
|
interleukin 2
|
1.588
|
|
CD38
|
CD38 molecule
|
1.582
|
|
EPO
|
erythropoietin
|
1.565
|
|
CD1C
|
CD1c molecule
|
1.544
|
|
F9
|
coagulation factor IX
|
1.538
|
|
C3
|
complement component 3
|
1.534
|
|
JAK2
|
Janus kinase 2
|
1.529
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.522
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.521
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
1.518
|
|
AFP
|
alpha-fetoprotein
|
1.518
|
|
TLR4
|
toll-like receptor 4
|
1.518
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.517
|
|
IL17A
|
interleukin 17A
|
1.513
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.51
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.509
|
|
CKB
|
creatine kinase, brain
|
1.507
|
|
CKM
|
creatine kinase, muscle
|
1.505
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.504
|
|
CA2
|
carbonic anhydrase II
|
1.503
|
|
IFNA2
|
interferon, alpha 2
|
1.499
|
|
IFNA13
|
interferon, alpha 13
|
1.496
|
|
IFNA4
|
interferon, alpha 4
|
1.494
|
|
IFNA16
|
interferon, alpha 16
|
1.492
|
|
IFNA8
|
interferon, alpha 8
|
1.491
|
|
IFNA10
|
interferon, alpha 10
|
1.491
|
|
PPOX
|
protoporphyrinogen oxidase
|
1.491
|
|
IFNA7
|
interferon, alpha 7
|
1.491
|
|
IFNA21
|
interferon, alpha 21
|
1.491
|
|
IFNA14
|
interferon, alpha 14
|
1.491
|
|
IFNA6
|
interferon, alpha 6
|
1.49
|
|
IFNA5
|
interferon, alpha 5
|
1.489
|
|
PF4V1
|
platelet factor 4 variant 1
|
1.483
|
|
ELN
|
elastin
|
1.482
|
|
CD1D
|
CD1d molecule
|
1.48
|
|
LTF
|
lactotransferrin
|
1.477
|
|
IFNA17
|
interferon, alpha 17
|
1.47
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
1.463
|
|
ESR1
|
estrogen receptor 1
|
1.458
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.453
|
|
PIK3C2A
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha
|
1.438
|
|
CD19
|
CD19 molecule
|
1.435
|
|
FGA
|
fibrinogen alpha chain
|
1.433
|
|
KNG1
|
kininogen 1
|
1.432
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
1.421
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
1.419
|
|
HMBS
|
hydroxymethylbilane synthase
|
1.417
|
|
ACE2
|
angiotensin I converting enzyme 2
|
1.412
|
|
PPIG
|
peptidylprolyl isomerase G (cyclophilin G)
|
1.411
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.409
|
|
CPOX
|
coproporphyrinogen oxidase
|
1.406
|
|
F11
|
coagulation factor XI
|
1.399
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.394
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.391
|
|
TRIM21
|
tripartite motif containing 21
|
1.389
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
1.374
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.37
|
|
FN1
|
fibronectin 1
|
1.369
|
|
AVP
|
arginine vasopressin
|
1.362
|
|
MMP9
|
matrix metallopeptidase 9
|
1.357
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.352
|
|
MB
|
myoglobin
|
1.349
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
1.349
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
1.343
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
1.33
|
|
C11ORF65
|
chromosome 11 open reading frame 65
|
1.327
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.322
|
|
ASPG
|
asparaginase
|
1.321
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.317
|
|
FIP1L1
|
factor interacting with PAPOLA and CPSF1
|
1.314
|
|
NPPB
|
natriuretic peptide B
|
1.312
|
|
PROS1
|
protein S (alpha)
|
1.311
|
|
CD27
|
CD27 molecule
|
1.311
|
|
UBR2
|
ubiquitin protein ligase E3 component n-recognin 2
|
1.31
|
|
HP
|
haptoglobin
|
1.31
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
1.308
|
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1
|
1.301
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
1.299
|
|
CTRB1
|
chymotrypsinogen B1
|
1.293
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.29
|
|
TLR2
|
toll-like receptor 2
|
1.288
|
|
PXDNL
|
peroxidasin-like
|
1.287
|
|
PXDN
|
peroxidasin
|
1.286
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
1.283
|
|
TP53
|
tumor protein p53
|
1.283
|
|
CTRB2
|
chymotrypsinogen B2
|
1.282
|
|
PGR
|
progesterone receptor
|
1.277
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
1.277
|
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
1.276
|
|
AGGF1
|
angiogenic factor with G patch and FHA domains 1
|
1.272
|
|
SELL
|
selectin L
|
1.269
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
1.266
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.265
|
|
KRT7
|
keratin 7, type II
|
1.265
|
|
ADA
|
adenosine deaminase
|
1.264
|
|
PDPN
|
podoplanin
|
1.258
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
1.25
|
|
TAC1
|
tachykinin, precursor 1
|
1.245
|
|
GP6
|
glycoprotein VI (platelet)
|
1.243
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.241
|
|
PROCR
|
protein C receptor, endothelial
|
1.24
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.236
|
|
LEAP2
|
liver expressed antimicrobial peptide 2
|
1.234
|
|
EDN1
|
endothelin 1
|
1.232
|
|
MMP2
|
matrix metallopeptidase 2
|
1.229
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
1.229
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.228
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.227
|
|
POMC
|
proopiomelanocortin
|
1.227
|
|
REN
|
renin
|
1.222
|
|
MMP3
|
matrix metallopeptidase 3
|
1.219
|
|
THPO
|
thrombopoietin
|
1.216
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.212
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
1.211
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.21
|
|
TTC16
|
tetratricopeptide repeat domain 16
|
1.209
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
1.203
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.201
|
|
FOXP3
|
forkhead box P3
|
1.198
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
1.195
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
1.195
|
|
ALAD
|
aminolevulinate dehydratase
|
1.193
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
1.182
|
|
HMOX1
|
heme oxygenase 1
|
1.176
|
|
MUC1
|
mucin 1, cell surface associated
|
1.175
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.168
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
1.162
|
|
FCRL3
|
Fc receptor-like 3
|
1.16
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.157
|
|
JUN
|
jun proto-oncogene
|
1.157
|
|
TTR
|
transthyretin
|
1.155
|
|
UBAC1
|
UBA domain containing 1
|
1.154
|
|
CD207
|
CD207 molecule, langerin
|
1.151
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.15
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
1.149
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.144
|
|
FGF7
|
fibroblast growth factor 7
|
1.14
|
|
GCG
|
glucagon
|
1.14
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
1.132
|
|
SELPLG
|
selectin P ligand
|
1.129
|
|
GTPBP1
|
GTP binding protein 1
|
1.127
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
1.113
|
|
IL18
|
interleukin 18
|
1.113
|
|
B2M
|
beta-2-microglobulin
|
1.112
|
|
EGFR
|
epidermal growth factor receptor
|
1.112
|
|
CD163
|
CD163 molecule
|
1.109
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.108
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.106
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.106
|
|
TACR1
|
tachykinin receptor 1
|
1.105
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
1.104
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.103
|
|
IL33
|
interleukin 33
|
1.102
|
|
CYP51A1
|
cytochrome P450, family 51, subfamily A, polypeptide 1
|
1.102
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
1.101
|
|
EGF
|
epidermal growth factor
|
1.098
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
1.098
|
|
MMP1
|
matrix metallopeptidase 1
|
1.097
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.093
|
|
PTH
|
parathyroid hormone
|
1.092
|
|
A2M
|
alpha-2-macroglobulin
|
1.091
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.091
|
|
TLR3
|
toll-like receptor 3
|
1.085
|
|
KLRC4
|
killer cell lectin-like receptor subfamily C, member 4
|
1.085
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.085
|
|
ENO1
|
enolase 1, (alpha)
|
1.083
|
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18
|
1.083
|
|
SST
|
somatostatin
|
1.082
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.082
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
1.08
|
|
FECH
|
ferrochelatase
|
1.08
|
|
ELANE
|
elastase, neutrophil expressed
|
1.078
|
|
MME
|
membrane metallo-endopeptidase
|
1.078
|
|
ACR
|
acrosin
|
1.073
|
|
ORM2
|
orosomucoid 2
|
1.073
|
|
FGF5
|
fibroblast growth factor 5
|
1.071
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.068
|
|
ORM1
|
orosomucoid 1
|
1.066
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.062
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.062
|
|
ANXA5
|
annexin A5
|
1.061
|
|
HPX
|
hemopexin
|
1.059
|
|
IL23R
|
interleukin 23 receptor
|
1.057
|
|
IL22
|
interleukin 22
|
1.057
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
1.056
|
|
MMP8
|
matrix metallopeptidase 8
|
1.056
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.055
|
|
FGF3
|
fibroblast growth factor 3
|
1.052
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
1.052
|
|
FGF16
|
fibroblast growth factor 16
|
1.051
|
|
FGF10
|
fibroblast growth factor 10
|
1.051
|
|
CD274
|
CD274 molecule
|
1.05
|
|
KDR
|
kinase insert domain receptor
|
1.05
|
|
VTN
|
vitronectin
|
1.047
|
|
FGF17
|
fibroblast growth factor 17
|
1.046
|
|
RBP7
|
retinol binding protein 7, cellular
|
1.044
|
|
VIM
|
vimentin
|
1.04
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
1.038
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
1.038
|
|
FGF22
|
fibroblast growth factor 22
|
1.038
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.037
|
|
CALB2
|
calbindin 2
|
1.037
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.036
|
|
FGF6
|
fibroblast growth factor 6
|
1.036
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
1.035
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
1.034
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.034
|
|
FGF20
|
fibroblast growth factor 20
|
1.033
|
|
PLAU
|
plasminogen activator, urokinase
|
1.031
|
|
FGF18
|
fibroblast growth factor 18
|
1.028
|
|
NELFCD
|
negative elongation factor complex member C/D
|
1.027
|
|
FGF4
|
fibroblast growth factor 4
|
1.027
|
|
CD5
|
CD5 molecule
|
1.026
|
|
CD40LG
|
CD40 ligand
|
1.026
|
|
GBP5
|
guanylate binding protein 5
|
1.025
|
|
TLR7
|
toll-like receptor 7
|
1.022
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.021
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.02
|
|
FGF9
|
fibroblast growth factor 9
|
1.018
|
|
MEFV
|
Mediterranean fever
|
1.016
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
1.014
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.013
|
|
MYOM2
|
myomesin 2
|
1.007
|
|
C4B
|
complement component 4B (Chido blood group)
|
1.006
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
1.003
|
|
HAMP
|
hepcidin antimicrobial peptide
|
1.002
|